Evalution of right ventricular function and prognosis of pulmonary arterial hypertension by right ventricular quantification echocardiography

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000032646

Enrollment

Unknown

Registered

2020-05-04

Start date

2020-06-01

Completion date

Unknown

Last updated

2020-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pulmonary arterial hypertension

Interventions

Patients with various causes of pulmonary hypertension:N/A

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Primary pulmonary hypertension; 2. Chronic thromboembolic pulmonary hypertension; 3. Portal hypertensive pulmonary hypertension; 4. Pulmonary arterial hypertension with adult congenital heart disease after surgical repair; 5. Pulmonary arterial hypertension with OSAHS; 6. Pulmonary arterial hypertension with connective tissue disease; 7. Hereditary pulmonary hypertension.

Exclusion criteria

Exclusion criteria: 1. The patient's condition is unstable. 2. The patients had contraindications with right heart catheters or magnetic resonance imaging. 3. The patients declined to participate in the study.

Design outcomes

Primary

Measure	Time frame
EDVRV;ESVRV;SVRV;RVEF3D;	—

Countries

China

Contacts

Public ContactMa Likun

The First Affiliated Hospital, University of Science and Technology of China

lkma@ustc.edu.cn+86 0551-62283339

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026